跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,041 条关于
“Telix Pharmaceuticals Limited”
全部
19,041
临床试验
1,604
药物
1,772
机构
3,198
资讯
12,467
2年前
Telix Pharmaceuticals Doses First Patient in Phase III ProstACT GLOBAL Study of TLX591 for Prostate Cancer
去年
Telix Pharmaceuticals' TLX250-CDx Phase III Trial for Kidney Cancer Imaging Doses First Patient in China
9个月前
Telix Pharmaceuticals Achieves Positive Phase 3 Results for Prostate Cancer Imaging Agent in China
去年
Telix Pharmaceuticals' TLX250-CDx Enters Phase II Trial for Recurrent Kidney Cancer Detection
4个月前
EDAP and Telix Partner to Advance Precision Prostate Cancer Treatment Through HIFU-PSMA PET Integration
2个月前
Telix Opens Australia's First Integrated Radiopharmaceutical Facility to Accelerate Cancer Theranostics
去年
FDA Grants Priority Review to TLX101-CDx for PET Imaging in Recurrent Glioma
7年前
FDA Issues Complete Response Letter for Telix's Kidney Cancer Imaging Agent TLX250-CDx
6个月前
Heidelberg Pharma Advances Novel ATAC Technology Platform with Multiple Cancer Candidates in Clinical Development
6个月前
Heidelberg Pharma Secures $45 Million Through Modified Licensing Agreement with HealthCare Royalty and Soleus Capital
第 1 页，共 1247 页
上一页
下一页
